About Biora Therapeutics
Biora Therapeutics is a company based in San Diego (United States) founded in 2010.. Biora Therapeutics has raised $116.62 million across 6 funding rounds from investors including Athyrium Capital Management, Davidson Kempner Capital Management and Highbridge. Biora Therapeutics offers products and services including BioJet Oral Therapeutic Delivery Platform and NaviCap Targeted Therapeutic Delivery. Biora Therapeutics operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, Lyndra, RedHill Biopharma and Cosmo Pharmaceuticals, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biora Therapeutics, Inc.
-
Annual Revenue
$4 K-98.69as on Dec 31, 2023
-
Net Profit
$-124.11 M-225.27as on Dec 31, 2023
-
EBITDA
$-66.59 M-9.39as on Dec 31, 2023
-
Total Equity Funding
$116.62 M (USD)
in 6 rounds
-
Latest Funding Round
$16.7 M (USD), Post-IPO
Dec 18, 2023
-
Investors
Athyrium Capital Management
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biora Therapeutics
Biora Therapeutics is a publicly listed company on the OTC with ticker symbol BIORQ in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biora Therapeutics
Biora Therapeutics offers a comprehensive portfolio of products and services, including BioJet Oral Therapeutic Delivery Platform and NaviCap Targeted Therapeutic Delivery. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides needle-free oral delivery of large molecules for chronic diseases.
Enables precise oral delivery of therapeutics using smart-pill systems.
Funding Insights of Biora Therapeutics
Biora Therapeutics has successfully raised a total of $116.62M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $16.7 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $16.7M
-
First Round
First Round
(12 Jun 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Post-IPO - Biora Therapeutics | Valuation |
investors |
|
| Apr, 2020 | Amount | Series C - Biora Therapeutics | Valuation |
investors |
|
| Nov, 2019 | Amount | Series C - Biora Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biora Therapeutics
Biora Therapeutics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Athyrium Capital Management, Davidson Kempner Capital Management and Highbridge. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Global investment firm focusing on credit and event-driven opportunities worldwide.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biora Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biora Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biora Therapeutics Comparisons
Competitors of Biora Therapeutics
Biora Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, Lyndra, RedHill Biopharma and Cosmo Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Innovates long-acting oral therapies to simplify patient medication regimens.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biora Therapeutics
Frequently Asked Questions about Biora Therapeutics
When was Biora Therapeutics founded?
Biora Therapeutics was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Biora Therapeutics located?
Biora Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Biora Therapeutics?
Adi Mohanty is the current CEO of Biora Therapeutics.
Is Biora Therapeutics a funded company?
Biora Therapeutics is a funded company, having raised a total of $116.62M across 6 funding rounds to date. The company's 1st funding round was a Series C of $31.12M, raised on Jun 12, 2013.
What is the annual revenue of Biora Therapeutics?
Annual revenue of Biora Therapeutics is $4K as on Dec 31, 2023.
What does Biora Therapeutics do?
Biora Therapeutics was founded in 2010 in San Diego, United States, within the biotechnology sector. Ingestible smart capsules are created for precise therapeutic delivery in the gastrointestinal tract. Inflammatory bowel diseases are addressed through this approach, with pipelines focused on ulcerative colitis, diabetes, and autoimmune conditions. Operations center on advancing these technologies for improved disease management.
Who are the top competitors of Biora Therapeutics?
Biora Therapeutics's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
What products or services does Biora Therapeutics offer?
Biora Therapeutics offers BioJet Oral Therapeutic Delivery Platform and NaviCap Targeted Therapeutic Delivery.
Is Biora Therapeutics publicly traded?
Yes, Biora Therapeutics is publicly traded on OTC under the ticker symbol BIORQ.
Who are Biora Therapeutics's investors?
Biora Therapeutics has 3 investors. Key investors include Athyrium Capital Management, Davidson Kempner Capital Management, and Highbridge.
What is Biora Therapeutics's ticker symbol?
The ticker symbol of Biora Therapeutics is BIORQ on OTC.